English
简体中文
Total: £ 56.28
Published Date: 2026-04-02 | Pages: 124 | Tables: 125 | Pharma & Healthcare
The global OTC Anti-Infective Products market was valued at US$ 14670 million in 2025 and is anticipated to reach US$ 18480 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on OTC Anti-Infective Products competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Anti-infectives are medicines that work to prevent or treat infections. Anti-infective drugs used for the purpose of killing or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites.
The OTC anti-infective products market is driven by the growing consumer demand for accessible and affordable healthcare solutions. With increasing awareness of self-care and the rising prevalence of minor infections like cuts, burns, and fungal conditions, consumers are turning to OTC products for quick relief and convenience. Additionally, the expansion of retail pharmacy chains and e-commerce platforms has improved the availability of OTC anti-infective products globally, further boosting market growth. Innovations in formulations, such as faster-acting and longer-lasting products, also contribute to market demand.
Despite its growth, the market faces challenges, including the risk of misuse or overuse of OTC anti-infective products, which can lead to antimicrobial resistance (AMR). Regulatory scrutiny is also increasing to ensure product safety and efficacy, which may delay product approvals and raise costs for manufacturers. Moreover, competition from alternative treatments, such as natural remedies or prescription medications, may limit the market potential for OTC anti-infective products, particularly in regions with stricter healthcare regulations.
Global core OTC anti-infective products manufacturers include Teva, MYLAN and NOVARTIS etc. The Top 3 companies hold a share above 10%. Asia-Pacific is the largest market, with a share about 38%, followed by North America and Europe with the share about 30% and 20%.
This report delivers a comprehensive overview of the global OTC Anti-Infective Products market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding OTC Anti-Infective Products. The OTC Anti-Infective Products market size, estimates, and forecasts are provided in terms of sales volume (M Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global OTC Anti-Infective Products market comprehensively. Regional market sizes by Type, by Sales Channel, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist OTC Anti-Infective Products manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Sales Channel, and by region.
Market Segmentation
By Company
Bayer
GSK
Teva
Johnson & Johnson
NOVARTIS
MYLAN
Sun Pharma
CR SANJIU
Cipla
Lingrui
Gilead Sciences
Pfizer
Bausch Health
Astellas Pharma
Roche
Segment by Type
Antifungal
Antibacterial
Antiviral
Antiseptics
Others
by Sales Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Sales Channel, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for OTC Anti-Infective Products manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines OTC Anti-Infective Products sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Sales Channel, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 OTC Anti-Infective Products Market Overview
1.1 Product Definition
1.2 OTC Anti-Infective Products by Type
1.2.1 Global OTC Anti-Infective Products Market Value by Type: 2025 vs 2032
1.2.2 Antifungal
1.2.3 Antibacterial
1.2.4 Antiviral
1.2.5 Antiseptics
1.2.6 Others
1.3 OTC Anti-Infective Products by Sales Channel
1.3.1 Global OTC Anti-Infective Products Market Value by Sales Channel: 2025 vs 2032
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global OTC Anti-Infective Products Market Size Estimates and Forecasts
1.4.1 Global OTC Anti-Infective Products Revenue 2021–2032
1.4.2 Global OTC Anti-Infective Products Sales 2021–2032
1.4.3 Global OTC Anti-Infective Products Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 OTC Anti-Infective Products Market Competition by Manufacturers
2.1 Global OTC Anti-Infective Products Sales Market Share by Manufacturers (2021–2026)
2.2 Global OTC Anti-Infective Products Revenue Market Share by Manufacturers (2021–2026)
2.3 Global OTC Anti-Infective Products Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of OTC Anti-Infective Products, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of OTC Anti-Infective Products, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of OTC Anti-Infective Products, Product Types and Applications
2.7 Global Key Manufacturers of OTC Anti-Infective Products, Date of Entry into the Industry
2.8 Global OTC Anti-Infective Products Market Competitive Situation and Trends
2.8.1 Global OTC Anti-Infective Products Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global OTC Anti-Infective Products Players Market Share by Revenue
2.8.3 Global OTC Anti-Infective Products Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global OTC Anti-Infective Products Market Scenario by Region
3.1 Global OTC Anti-Infective Products Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global OTC Anti-Infective Products Sales by Region: 2021–2032
3.2.1 Global OTC Anti-Infective Products Sales by Region: 2021–2026
3.2.2 Global OTC Anti-Infective Products Sales by Region: 2027–2032
3.3 Global OTC Anti-Infective Products Revenue by Region: 2021–2032
3.3.1 Global OTC Anti-Infective Products Revenue by Region: 2021–2026
3.3.2 Global OTC Anti-Infective Products Revenue by Region: 2027–2032
3.4 North America OTC Anti-Infective Products Market Facts & Figures by Country
3.4.1 North America OTC Anti-Infective Products Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America OTC Anti-Infective Products Sales by Country (2021–2032)
3.4.3 North America OTC Anti-Infective Products Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe OTC Anti-Infective Products Market Facts & Figures by Country
3.5.1 Europe OTC Anti-Infective Products Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe OTC Anti-Infective Products Sales by Country (2021–2032)
3.5.3 Europe OTC Anti-Infective Products Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific OTC Anti-Infective Products Market Facts & Figures by Region
3.6.1 Asia Pacific OTC Anti-Infective Products Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific OTC Anti-Infective Products Sales by Region (2021–2032)
3.6.3 Asia Pacific OTC Anti-Infective Products Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America OTC Anti-Infective Products Market Facts & Figures by Country
3.7.1 Latin America OTC Anti-Infective Products Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America OTC Anti-Infective Products Sales by Country (2021–2032)
3.7.3 Latin America OTC Anti-Infective Products Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa OTC Anti-Infective Products Market Facts & Figures by Country
3.8.1 Middle East and Africa OTC Anti-Infective Products Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa OTC Anti-Infective Products Sales by Country (2021–2032)
3.8.3 Middle East and Africa OTC Anti-Infective Products Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global OTC Anti-Infective Products Sales by Type (2021–2032)
4.1.1 Global OTC Anti-Infective Products Sales by Type (2021–2026)
4.1.2 Global OTC Anti-Infective Products Sales by Type (2027–2032)
4.1.3 Global OTC Anti-Infective Products Sales Market Share by Type (2021–2032)
4.2 Global OTC Anti-Infective Products Revenue by Type (2021–2032)
4.2.1 Global OTC Anti-Infective Products Revenue by Type (2021–2026)
4.2.2 Global OTC Anti-Infective Products Revenue by Type (2027–2032)
4.2.3 Global OTC Anti-Infective Products Revenue Market Share by Type (2021–2032)
4.3 Global OTC Anti-Infective Products Price by Type (2021–2032)
5 Segment by Sales Channel
5.1 Global OTC Anti-Infective Products Sales by Sales Channel (2021–2032)
5.1.1 Global OTC Anti-Infective Products Sales by Sales Channel (2021–2026)
5.1.2 Global OTC Anti-Infective Products Sales by Sales Channel (2027–2032)
5.1.3 Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2021–2032)
5.2 Global OTC Anti-Infective Products Revenue by Sales Channel (2021–2032)
5.2.1 Global OTC Anti-Infective Products Revenue by Sales Channel (2021–2026)
5.2.2 Global OTC Anti-Infective Products Revenue by Sales Channel (2027–2032)
5.2.3 Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2021–2032)
5.3 Global OTC Anti-Infective Products Price by Sales Channel (2021–2032)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer OTC Anti-Infective Products Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Bayer OTC Anti-Infective Products Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK OTC Anti-Infective Products Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 GSK OTC Anti-Infective Products Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva OTC Anti-Infective Products Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Teva OTC Anti-Infective Products Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Company Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson OTC Anti-Infective Products Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Johnson & Johnson OTC Anti-Infective Products Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 NOVARTIS
6.5.1 NOVARTIS Company Information
6.5.2 NOVARTIS Description and Business Overview
6.5.3 NOVARTIS OTC Anti-Infective Products Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 NOVARTIS OTC Anti-Infective Products Product Portfolio
6.5.5 NOVARTIS Recent Developments/Updates
6.6 MYLAN
6.6.1 MYLAN Company Information
6.6.2 MYLAN Description and Business Overview
6.6.3 MYLAN OTC Anti-Infective Products Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 MYLAN OTC Anti-Infective Products Product Portfolio
6.6.5 MYLAN Recent Developments/Updates
6.7 Sun Pharma
6.7.1 Sun Pharma Company Information
6.7.2 Sun Pharma Description and Business Overview
6.7.3 Sun Pharma OTC Anti-Infective Products Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Sun Pharma OTC Anti-Infective Products Product Portfolio
6.7.5 Sun Pharma Recent Developments/Updates
6.8 CR SANJIU
6.8.1 CR SANJIU Company Information
6.8.2 CR SANJIU Description and Business Overview
6.8.3 CR SANJIU OTC Anti-Infective Products Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 CR SANJIU OTC Anti-Infective Products Product Portfolio
6.8.5 CR SANJIU Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Company Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla OTC Anti-Infective Products Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Cipla OTC Anti-Infective Products Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Lingrui
6.10.1 Lingrui Company Information
6.10.2 Lingrui Description and Business Overview
6.10.3 Lingrui OTC Anti-Infective Products Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Lingrui OTC Anti-Infective Products Product Portfolio
6.10.5 Lingrui Recent Developments/Updates
6.11 Gilead Sciences
6.11.1 Gilead Sciences Company Information
6.11.2 Gilead Sciences Description and Business Overview
6.11.3 Gilead Sciences OTC Anti-Infective Products Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Gilead Sciences OTC Anti-Infective Products Product Portfolio
6.11.5 Gilead Sciences Recent Developments/Updates
6.12 Pfizer
6.12.1 Pfizer Company Information
6.12.2 Pfizer Description and Business Overview
6.12.3 Pfizer OTC Anti-Infective Products Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Pfizer OTC Anti-Infective Products Product Portfolio
6.12.5 Pfizer Recent Developments/Updates
6.13 Bausch Health
6.13.1 Bausch Health Company Information
6.13.2 Bausch Health Description and Business Overview
6.13.3 Bausch Health OTC Anti-Infective Products Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Bausch Health OTC Anti-Infective Products Product Portfolio
6.13.5 Bausch Health Recent Developments/Updates
6.14 Astellas Pharma
6.14.1 Astellas Pharma Company Information
6.14.2 Astellas Pharma Description and Business Overview
6.14.3 Astellas Pharma OTC Anti-Infective Products Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Astellas Pharma OTC Anti-Infective Products Product Portfolio
6.14.5 Astellas Pharma Recent Developments/Updates
6.15 Roche
6.15.1 Roche Company Information
6.15.2 Roche Description and Business Overview
6.15.3 Roche OTC Anti-Infective Products Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Roche OTC Anti-Infective Products Product Portfolio
6.15.5 Roche Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 OTC Anti-Infective Products Industry Chain Analysis
7.2 OTC Anti-Infective Products Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 OTC Anti-Infective Products Production Mode & Process Analysis
7.4 OTC Anti-Infective Products Sales and Marketing
7.4.1 OTC Anti-Infective Products Sales Channels
7.4.2 OTC Anti-Infective Products Distributors
7.5 OTC Anti-Infective Products Customer Analysis
8 OTC Anti-Infective Products Market Dynamics
8.1 OTC Anti-Infective Products Industry Trends
8.2 OTC Anti-Infective Products Market Drivers
8.3 OTC Anti-Infective Products Market Challenges
8.4 OTC Anti-Infective Products Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global OTC Anti-Infective Products Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global OTC Anti-Infective Products Market Value by Sales Channel (US$ Million), 2025 vs 2032
Table 3. Global OTC Anti-Infective Products Market Competitive Situation by Manufacturers in 2025
Table 4. Global OTC Anti-Infective Products Sales (M Units) of Key Manufacturers (2021–2026)
Table 5. Global OTC Anti-Infective Products Sales Market Share by Manufacturers (2021–2026)
Table 6. Global OTC Anti-Infective Products Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global OTC Anti-Infective Products Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market OTC Anti-Infective Products Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of OTC Anti-Infective Products, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of OTC Anti-Infective Products, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of OTC Anti-Infective Products, Product Types and Applications
Table 12. Global Key Manufacturers of OTC Anti-Infective Products, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global OTC Anti-Infective Products Companies by Tier (Tier 1, Tier 2, Tier 3), based on OTC Anti-Infective Products Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global OTC Anti-Infective Products Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global OTC Anti-Infective Products Sales by Region (M Units), 2021–2026
Table 18. Global OTC Anti-Infective Products Sales Market Share by Region (2021–2026)
Table 19. Global OTC Anti-Infective Products Sales by Region (M Units), 2027–2032
Table 20. Global OTC Anti-Infective Products Sales Market Share by Region (2027–2032)
Table 21. Global OTC Anti-Infective Products Revenue by Region (US$ Million), 2021–2026
Table 22. Global OTC Anti-Infective Products Revenue Market Share by Region (2021–2026)
Table 23. Global OTC Anti-Infective Products Revenue by Region (US$ Million), 2027–2032
Table 24. Global OTC Anti-Infective Products Revenue Market Share by Region (2027–2032)
Table 25. North America OTC Anti-Infective Products Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America OTC Anti-Infective Products Sales by Country (M Units), 2021–2026
Table 27. North America OTC Anti-Infective Products Sales by Country (M Units), 2027–2032
Table 28. North America OTC Anti-Infective Products Revenue by Country (US$ Million), 2021–2026
Table 29. North America OTC Anti-Infective Products Revenue by Country (US$ Million), 2027–2032
Table 30. Europe OTC Anti-Infective Products Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe OTC Anti-Infective Products Sales by Country (M Units), 2021–2026
Table 32. Europe OTC Anti-Infective Products Sales by Country (M Units), 2027–2032
Table 33. Europe OTC Anti-Infective Products Revenue by Country (US$ Million), 2021–2026
Table 34. Europe OTC Anti-Infective Products Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific OTC Anti-Infective Products Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific OTC Anti-Infective Products Sales by Region (M Units), 2021–2026
Table 37. Asia Pacific OTC Anti-Infective Products Sales by Region (M Units), 2027–2032
Table 38. Asia Pacific OTC Anti-Infective Products Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific OTC Anti-Infective Products Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America OTC Anti-Infective Products Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America OTC Anti-Infective Products Sales by Country (M Units), 2021–2026
Table 42. Latin America OTC Anti-Infective Products Sales by Country (M Units), 2027–2032
Table 43. Latin America OTC Anti-Infective Products Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America OTC Anti-Infective Products Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa OTC Anti-Infective Products Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa OTC Anti-Infective Products Sales by Country (M Units), 2021–2026
Table 47. Middle East and Africa OTC Anti-Infective Products Sales by Country (M Units), 2027–2032
Table 48. Middle East and Africa OTC Anti-Infective Products Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa OTC Anti-Infective Products Revenue by Country (US$ Million), 2027–2032
Table 50. Global OTC Anti-Infective Products Sales (M Units) by Type (2021–2026)
Table 51. Global OTC Anti-Infective Products Sales (M Units) by Type (2027–2032)
Table 52. Global OTC Anti-Infective Products Sales Market Share by Type (2021–2026)
Table 53. Global OTC Anti-Infective Products Sales Market Share by Type (2027–2032)
Table 54. Global OTC Anti-Infective Products Revenue (US$ Million) by Type (2021–2026)
Table 55. Global OTC Anti-Infective Products Revenue (US$ Million) by Type (2027–2032)
Table 56. Global OTC Anti-Infective Products Revenue Market Share by Type (2021–2026)
Table 57. Global OTC Anti-Infective Products Revenue Market Share by Type (2027–2032)
Table 58. Global OTC Anti-Infective Products Price (US$/Unit) by Type (2021–2026)
Table 59. Global OTC Anti-Infective Products Price (US$/Unit) by Type (2027–2032)
Table 60. Global OTC Anti-Infective Products Sales (M Units) by Sales Channel (2021–2026)
Table 61. Global OTC Anti-Infective Products Sales (M Units) by Sales Channel (2027–2032)
Table 62. Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2021–2026)
Table 63. Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2027–2032)
Table 64. Global OTC Anti-Infective Products Revenue (US$ Million) by Sales Channel (2021–2026)
Table 65. Global OTC Anti-Infective Products Revenue (US$ Million) by Sales Channel (2027–2032)
Table 66. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2021–2026)
Table 67. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2027–2032)
Table 68. Global OTC Anti-Infective Products Price (US$/Unit) by Sales Channel (2021–2026)
Table 69. Global OTC Anti-Infective Products Price (US$/Unit) by Sales Channel (2027–2032)
Table 70. Bayer Company Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Bayer OTC Anti-Infective Products Product
Table 74. Bayer Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. GSK OTC Anti-Infective Products Product
Table 79. GSK Recent Developments/Updates
Table 80. Teva Company Information
Table 81. Teva Description and Business Overview
Table 82. Teva OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Teva OTC Anti-Infective Products Product
Table 84. Teva Recent Developments/Updates
Table 85. Johnson & Johnson Company Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Johnson & Johnson OTC Anti-Infective Products Product
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. NOVARTIS Company Information
Table 91. NOVARTIS Description and Business Overview
Table 92. NOVARTIS OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. NOVARTIS OTC Anti-Infective Products Product
Table 94. NOVARTIS Recent Developments/Updates
Table 95. MYLAN Company Information
Table 96. MYLAN Description and Business Overview
Table 97. MYLAN OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. MYLAN OTC Anti-Infective Products Product
Table 99. MYLAN Recent Developments/Updates
Table 100. Sun Pharma Company Information
Table 101. Sun Pharma Description and Business Overview
Table 102. Sun Pharma OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Sun Pharma OTC Anti-Infective Products Product
Table 104. Sun Pharma Recent Developments/Updates
Table 105. CR SANJIU Company Information
Table 106. CR SANJIU Description and Business Overview
Table 107. CR SANJIU OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. CR SANJIU OTC Anti-Infective Products Product
Table 109. CR SANJIU Recent Developments/Updates
Table 110. Cipla Company Information
Table 111. Cipla Description and Business Overview
Table 112. Cipla OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Cipla OTC Anti-Infective Products Product
Table 114. Cipla Recent Developments/Updates
Table 115. Lingrui Company Information
Table 116. Lingrui Description and Business Overview
Table 117. Lingrui OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Lingrui OTC Anti-Infective Products Product
Table 119. Lingrui Recent Developments/Updates
Table 120. Gilead Sciences Company Information
Table 121. Gilead Sciences Description and Business Overview
Table 122. Gilead Sciences OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Gilead Sciences OTC Anti-Infective Products Product
Table 124. Gilead Sciences Recent Developments/Updates
Table 125. Pfizer Company Information
Table 126. Pfizer Description and Business Overview
Table 127. Pfizer OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Pfizer OTC Anti-Infective Products Product
Table 129. Pfizer Recent Developments/Updates
Table 130. Bausch Health Company Information
Table 131. Bausch Health Description and Business Overview
Table 132. Bausch Health OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Bausch Health OTC Anti-Infective Products Product
Table 134. Bausch Health Recent Developments/Updates
Table 135. Astellas Pharma Company Information
Table 136. Astellas Pharma Description and Business Overview
Table 137. Astellas Pharma OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Astellas Pharma OTC Anti-Infective Products Product
Table 139. Astellas Pharma Recent Developments/Updates
Table 140. Roche Company Information
Table 141. Roche Description and Business Overview
Table 142. Roche OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Roche OTC Anti-Infective Products Product
Table 144. Roche Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. OTC Anti-Infective Products Distributors List
Table 148. OTC Anti-Infective Products Customers List
Table 149. OTC Anti-Infective Products Market Trends
Table 150. OTC Anti-Infective Products Market Drivers
Table 151. OTC Anti-Infective Products Market Challenges
Table 152. OTC Anti-Infective Products Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of OTC Anti-Infective Products
Figure 2. Global OTC Anti-Infective Products Market Value by Type (US$ Million), 2021–2032
Figure 3. Global OTC Anti-Infective Products Market Share by Type: 2025 & 2032
Figure 4. Antifungal Product Picture
Figure 5. Antibacterial Product Picture
Figure 6. Antiviral Product Picture
Figure 7. Antiseptics Product Picture
Figure 8. Others Product Picture
Figure 9. Global OTC Anti-Infective Products Market Value by Sales Channel (US$ Million), 2021–2032
Figure 10. Global OTC Anti-Infective Products Market Share by Sales Channel: 2025 & 2032
Figure 11. Hospital Pharmacies
Figure 12. Retail Pharmacies
Figure 13. Online Pharmacies
Figure 14. Global OTC Anti-Infective Products Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global OTC Anti-Infective Products Market Size (US$ Million), 2021–2032
Figure 16. Global OTC Anti-Infective Products Sales (M Units), 2021–2032
Figure 17. Global OTC Anti-Infective Products Average Price (US$/Unit), 2021–2032
Figure 18. OTC Anti-Infective Products Report Years Considered
Figure 19. OTC Anti-Infective Products Sales Share by Manufacturers in 2025
Figure 20. Global OTC Anti-Infective Products Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global OTC Anti-Infective Products Players: Market Share by Revenue in OTC Anti-Infective Products in 2025
Figure 22. OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global OTC Anti-Infective Products Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America OTC Anti-Infective Products Sales Market Share by Country (2021–2032)
Figure 25. North America OTC Anti-Infective Products Revenue Market Share by Country (2021–2032)
Figure 26. United States OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe OTC Anti-Infective Products Sales Market Share by Country (2021–2032)
Figure 29. Europe OTC Anti-Infective Products Revenue Market Share by Country (2021–2032)
Figure 30. Germany OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific OTC Anti-Infective Products Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific OTC Anti-Infective Products Revenue Market Share by Region (2021–2032)
Figure 37. China OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Indonesia OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Thailand OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Malaysia OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Latin America OTC Anti-Infective Products Sales Market Share by Country (2021–2032)
Figure 47. Latin America OTC Anti-Infective Products Revenue Market Share by Country (2021–2032)
Figure 48. Mexico OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Brazil OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Argentina OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Country (2021–2032)
Figure 52. Middle East and Africa OTC Anti-Infective Products Revenue Market Share by Country (2021–2032)
Figure 53. Turkey OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Saudi Arabia OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. UAE OTC Anti-Infective Products Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Global Sales Market Share of OTC Anti-Infective Products by Type (2021–2032)
Figure 57. Global Revenue Market Share of OTC Anti-Infective Products by Type (2021–2032)
Figure 58. Global OTC Anti-Infective Products Price (US$/Unit) by Type (2021–2032)
Figure 59. Global Sales Market Share of OTC Anti-Infective Products by Sales Channel (2021–2032)
Figure 60. Global Revenue Market Share of OTC Anti-Infective Products by Sales Channel (2021–2032)
Figure 61. Global OTC Anti-Infective Products Price (US$/Unit) by Sales Channel (2021–2032)
Figure 62. OTC Anti-Infective Products Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
